Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/DIFENADEX 25 MG CAPSULAS DURAS

Approved

STANDARD

DIFENADEX 25 MG CAPSULAS DURAS

Laboratorios Normon S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Sep 12, 2022
Approval ID: 28378895c316e9ea
Company: Laboratorios Normon S.A.
Type: Standard

Approval Details

Approval Id: 28378895c316e9ea
Drug Cima Aemps Name: DIFENADEX 25 MG CAPSULAS DURAS
Register Number: 88076
Holder Company Name: Laboratorios Normon S.A.
Marketing Company Name: Laboratorios Normon S.A.
Authorization Date: 2022-09-12
Dosage Form: CÁPSULA DURA
Dose: 25 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Laboratorios Normon S.A.

Active Ingredients

DEXKETOPROFENO TROMETAMOL

36,9 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 12, 2022

Approval ID

28378895c316e9ea

Type

Standard

Back to CIMA-AEMPS Approvals

DIFENADEX 25 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details